COVID-19 Home
We are here to support you during the COVID-19 pandemic.
Karius is your partner in diagnosing infections.
Genomic Insights for Infectious Diseases
The Karius® Test is a blood test based on next-generation sequencing of microbial cell-free DNA. It can identify and quantify over 1,000 clinically relevant pathogens including bacteria, DNA viruses, fungi, and parasites. Applications include complicated pneumonia, infections in immunocompromised patients, and endocarditis.
We use genomics and AI to advance infectious disease diagnostics.
Microbial cell-free DNA
Karius provides unique genomic insights by detecting microbial cell-free DNA (mcfDNA) circulating in the bloodstream from pathogens causing an acute infection. Proprietary technology efficiently extracts mcfDNA directly from blood and depletes the strong human background signal and environmental contaminants.
Karius AI technology
Advanced machine learning algorithms allow analysis of complex genomic data in real-time. Proprietary reference genome databases are constantly refined as more data becomes available.
Ryan Visits Karius Headquarters
"That's really what it's all about. Trying to figure out what people have in time to save them."
Ryan S
Patient was reimbursed for travel and expenses related to the video shoot.
The latest from Karius
Published studies demonstrate the clinical impact of the Karius Test.
10+ publications
40+ abstracts
10+ clinical trials
References:
1. Fauci AS. et al, Emerging Infect Dis. 2005 Apr;11(4):519-25
2. Jain et al, NEJM. 2015 Dec 10;373(24):2382.
3. Gupta S. et al, Chest. 2016; 150:1251-1259